614 related articles for article (PubMed ID: 34782790)
1. Dexamethasone modulates immature neutrophils and interferon programming in severe COVID-19.
Sinha S; Rosin NL; Arora R; Labit E; Jaffer A; Cao L; Farias R; Nguyen AP; de Almeida LGN; Dufour A; Bromley A; McDonald B; Gillrie MR; Fritzler MJ; Yipp BG; Biernaskie J
Nat Med; 2022 Jan; 28(1):201-211. PubMed ID: 34782790
[TBL] [Abstract][Full Text] [Related]
2. A functionally distinct neutrophil landscape in severe COVID-19 reveals opportunities for adjunctive therapies.
Panda R; Castanheira FV; Schlechte JM; Surewaard BG; Shim HB; Zucoloto AZ; Slavikova Z; Yipp BG; Kubes P; McDonald B
JCI Insight; 2022 Jan; 7(2):. PubMed ID: 34908534
[TBL] [Abstract][Full Text] [Related]
3. LOX-1-Expressing Immature Neutrophils Identify Critically-Ill COVID-19 Patients at Risk of Thrombotic Complications.
Combadière B; Adam L; Guillou N; Quentric P; Rosenbaum P; Dorgham K; Bonduelle O; Parizot C; Sauce D; Mayaux J; Luyt CE; Boissonnas A; Amoura Z; Pourcher V; Miyara M; Gorochov G; Guihot A; Combadière C
Front Immunol; 2021; 12():752612. PubMed ID: 34616409
[TBL] [Abstract][Full Text] [Related]
4. Tracheal aspirate RNA sequencing identifies distinct immunological features of COVID-19 ARDS.
Sarma A; Christenson SA; Byrne A; Mick E; Pisco AO; DeVoe C; Deiss T; Ghale R; Zha BS; Tsitsiklis A; Jauregui A; Moazed F; Detweiler AM; Spottiswoode N; Sinha P; Neff N; Tan M; Serpa PH; Willmore A; Ansel KM; Wilson JG; Leligdowicz A; Siegel ER; Sirota M; DeRisi JL; Matthay MA; ; Hendrickson CM; Kangelaris KN; Krummel MF; Woodruff PG; Erle DJ; Calfee CS; Langelier CR
Nat Commun; 2021 Aug; 12(1):5152. PubMed ID: 34446707
[TBL] [Abstract][Full Text] [Related]
5. A specific low-density neutrophil population correlates with hypercoagulation and disease severity in hospitalized COVID-19 patients.
Morrissey SM; Geller AE; Hu X; Tieri D; Ding C; Klaes CK; Cooke EA; Woeste MR; Martin ZC; Chen O; Bush SE; Zhang HG; Cavallazzi R; Clifford SP; Chen J; Ghare S; Barve SS; Cai L; Kong M; Rouchka EC; McLeish KR; Uriarte SM; Watson CT; Huang J; Yan J
JCI Insight; 2021 May; 6(9):. PubMed ID: 33986193
[TBL] [Abstract][Full Text] [Related]
6. Cell-Type-Specific Immune Dysregulation in Severely Ill COVID-19 Patients.
Yao C; Bora SA; Parimon T; Zaman T; Friedman OA; Palatinus JA; Surapaneni NS; Matusov YP; Cerro Chiang G; Kassar AG; Patel N; Green CER; Aziz AW; Suri H; Suda J; Lopez AA; Martins GA; Stripp BR; Gharib SA; Goodridge HS; Chen P
Cell Rep; 2021 Jan; 34(1):108590. PubMed ID: 33357411
[TBL] [Abstract][Full Text] [Related]
7. Heterogeneity of immune cells and their communications unveiled by transcriptome profiling in acute inflammatory lung injury.
Kang ZY; Huang QY; Zhen NX; Xuan NX; Zhou QC; Zhao J; Cui W; Zhang ZC; Tian BP
Front Immunol; 2024; 15():1382449. PubMed ID: 38745657
[TBL] [Abstract][Full Text] [Related]
8. COVID-19 and Neutrophils: The Relationship between Hyperinflammation and Neutrophil Extracellular Traps.
Borges L; Pithon-Curi TC; Curi R; Hatanaka E
Mediators Inflamm; 2020; 2020():8829674. PubMed ID: 33343232
[TBL] [Abstract][Full Text] [Related]
9. High dose dexamethasone treatment for Acute Respiratory Distress Syndrome secondary to COVID-19: a structured summary of a study protocol for a randomised controlled trial.
Maskin LP; Olarte GL; Palizas F; Velo AE; Lurbet MF; Bonelli I; Baredes ND; Rodríguez PO
Trials; 2020 Aug; 21(1):743. PubMed ID: 32843098
[TBL] [Abstract][Full Text] [Related]
10. The Longitudinal Immune Response to Coronavirus Disease 2019: Chasing the Cytokine Storm.
Chau AS; Weber AG; Maria NI; Narain S; Liu A; Hajizadeh N; Malhotra P; Bloom O; Marder G; Kaplan B
Arthritis Rheumatol; 2021 Jan; 73(1):23-35. PubMed ID: 32929876
[TBL] [Abstract][Full Text] [Related]
11. The Role and Therapeutic Potential of NF-kappa-B Pathway in Severe COVID-19 Patients.
Hariharan A; Hakeem AR; Radhakrishnan S; Reddy MS; Rela M
Inflammopharmacology; 2021 Feb; 29(1):91-100. PubMed ID: 33159646
[TBL] [Abstract][Full Text] [Related]
12. Dexamethasone attenuates interferon-related cytokine hyperresponsiveness in COVID-19 patients.
Engel JJ; van der Made CI; Keur N; Setiabudiawan T; Röring RJ; Damoraki G; Dijkstra H; Lemmers H; Ioannou S; Poulakou G; van der Meer JWM; Giamarellos-Bourboulis EJ; Kumar V; van de Veerdonk FL; Netea MG; Ziogas A
Front Immunol; 2023; 14():1233318. PubMed ID: 37614228
[TBL] [Abstract][Full Text] [Related]
13. Effect of Dexamethasone on Days Alive and Ventilator-Free in Patients With Moderate or Severe Acute Respiratory Distress Syndrome and COVID-19: The CoDEX Randomized Clinical Trial.
Tomazini BM; Maia IS; Cavalcanti AB; Berwanger O; Rosa RG; Veiga VC; Avezum A; Lopes RD; Bueno FR; Silva MVAO; Baldassare FP; Costa ELV; Moura RAB; Honorato MO; Costa AN; Damiani LP; Lisboa T; Kawano-Dourado L; Zampieri FG; Olivato GB; Righy C; Amendola CP; Roepke RML; Freitas DHM; Forte DN; Freitas FGR; Fernandes CCF; Melro LMG; Junior GFS; Morais DC; Zung S; Machado FR; Azevedo LCP;
JAMA; 2020 Oct; 324(13):1307-1316. PubMed ID: 32876695
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of dexamethasone treatment for patients with the acute respiratory distress syndrome caused by COVID-19: study protocol for a randomized controlled superiority trial.
Villar J; Añón JM; Ferrando C; Aguilar G; Muñoz T; Ferreres J; Ambrós A; Aldecoa C; Suárez-Sipmann F; Thorpe KE; Jüni P; Slutsky AS;
Trials; 2020 Aug; 21(1):717. PubMed ID: 32799933
[TBL] [Abstract][Full Text] [Related]
15. Self-sustaining IL-8 loops drive a prothrombotic neutrophil phenotype in severe COVID-19.
Kaiser R; Leunig A; Pekayvaz K; Popp O; Joppich M; Polewka V; Escaig R; Anjum A; Hoffknecht ML; Gold C; Brambs S; Engel A; Stockhausen S; Knottenberg V; Titova A; Haji M; Scherer C; Muenchhoff M; Hellmuth JC; Saar K; Schubert B; Hilgendorff A; Schulz C; Kääb S; Zimmer R; Hübner N; Massberg S; Mertins P; Nicolai L; Stark K
JCI Insight; 2021 Sep; 6(18):. PubMed ID: 34403366
[TBL] [Abstract][Full Text] [Related]
16. Inactivated SARS-CoV-2 induces acute respiratory distress syndrome in human ACE2-transgenic mice.
Bi Z; Hong W; Que H; He C; Ren W; Yang J; Lu T; Chen L; Lu S; Peng X; Wei X
Signal Transduct Target Ther; 2021 Dec; 6(1):439. PubMed ID: 34952899
[TBL] [Abstract][Full Text] [Related]
17. Polymorphism in interferon alpha/beta receptor contributes to glucocorticoid response and outcome of ARDS and COVID-19.
Jalkanen J; Khan S; Elima K; Huttunen T; Wang N; Hollmén M; Elo LL; Jalkanen S
Crit Care; 2023 Mar; 27(1):112. PubMed ID: 36927455
[TBL] [Abstract][Full Text] [Related]
18. Repurposing Multiple-Molecule Drugs for COVID-19-Associated Acute Respiratory Distress Syndrome and Non-Viral Acute Respiratory Distress Syndrome via a Systems Biology Approach and a DNN-DTI Model Based on Five Drug Design Specifications.
Ting CT; Chen BS
Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35409008
[TBL] [Abstract][Full Text] [Related]
19. Plasma Gradient of Soluble Urokinase-Type Plasminogen Activator Receptor Is Linked to Pathogenic Plasma Proteome and Immune Transcriptome and Stratifies Outcomes in Severe COVID-19.
Sarif J; Raychaudhuri D; D'Rozario R; Bandopadhyay P; Singh P; Mehta P; Hoque MA; Sinha BP; Kushwaha M; Sahni S; Devi P; Chattopadhyay P; Paul SR; Ray Y; Chaudhuri K; Banerjee S; Majumdar D; Saha B; Sarkar BS; Bhattacharya P; Chatterjee S; Paul S; Ghosh P; Pandey R; Sengupta S; Ganguly D
Front Immunol; 2021; 12():738093. PubMed ID: 34777349
[TBL] [Abstract][Full Text] [Related]
20. High-dose dexamethasone treatment for COVID-19 severe acute respiratory distress syndrome: a retrospective study.
Vecchié A; Batticciotto A; Tangianu F; Bonaventura A; Pennella B; Abenante A; Corso R; Grazioli S; Mumoli N; Para O; Maresca AM; Dalla Gasperina D; Dentali F
Intern Emerg Med; 2021 Oct; 16(7):1913-1919. PubMed ID: 34275096
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
